$1.96
+0.14 (+7.69%)
Open$1.83
Previous Close$1.82
Day High$2.02
Day Low$1.81
52W High$8.54
52W Low$1.77
Volume—
Avg Volume480.3K
Market Cap88.68M
P/E Ratio—
EPS$-0.87
SectorBiotechnology
Analyst Ratings
Strong Buy
11 analysts
Price Target
+174.0% upside
Current
$1.96
$1.96
Target
$5.37
$5.37
$3.28
$5.37 avg
$6.50
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 8.5K | 95.1K | 62.40M |
| Net Income | -36,866,507 | -369,898,063 | -13,759,336 |
| Profit Margin | -401,812.5% | -381,721.9% | -22.1% |
| EBITDA | -37,808,741 | -400,427,022 | -15,040,886 |
| Free Cash Flow | — | — | -13,384,851 |
| Rev Growth | -91.0% | -91.0% | +12.2% |
| Debt/Equity | — | — | 0.54 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $294.45 | -0.18% | 49.3 | 509.50B |
| AMGN | Amgen Inc | $467.06 | -0.22% | 26.5 | 248.84B |
| GILD | Gilead Sciences Inc | $167.95 | -1.05% | — | 208.28B |
| VRTX | Vertex Pharmaceuticals Inc | $542.62 | -0.81% | 34.5 | 137.12B |
| REGN | Regeneron Pharmaceuticals | $951.19 | -0.86% | 19.4 | 93.39B |
| ALNY | Alnylam Pharmaceuticals Inc | $156.65 | -2.00% | 7.7 | 20.98B |